The position
This is a 1-year contract-based position. The sales territory coverage areas are Busan and Gyeongnam and the role involves executing the sales and marketing strategy to achieve the company's business and financial targets for the Obesity brand, improving the treatment experience for people living with Obesity across the Patient Journey. Key tasks include, but not limited to: Driving Sales: Deliver given sales performance versus targets & marketing objectives. Develop and manage long term relationships/networks with HCPs and KOLs. Detail follow up and call evaluation on field visits. Ensure high quality call (planned field days). Analysis & Planning: Responsible for proactively conducting customer segmentation and targeting to find out right customers for right patient of Obesity. Develop and adjust call plan to exploit new business. Collect, store & report data about customers, field activities including competitor activities. Customer engagement & Disease awareness: Participate in congress promotional activities and symposia. Develop customer awareness of Novo Nordisk in the area of obesity. Provide standard medical information in response to clinical requests. Functional collaboration: Work with product manager and commercial manager towards territory business planning and the identification of new business opportunities. Provide feedback to product manager for the development of the local marketing strategy, product positioning, communication and support services. Compliance: Work according to business ethic procedures, local laws, NN Way and NN policies and guidelines. Building and strengthening customer relationship with key stakeholders. Qualifications Graduate University or same level of educational background. Min 3 years’ experience in pharmaceutical industry or related industry like medical devices or healthcare industry. Proven track records of sales success within industry. Territory sales analysis and territory management will be critical. Experience in out of pocket market - desirable. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care.Obesity Medical Representative, Busan & Gyeongnam (1 Year), Busan
Free
Obesity Medical Representative, Busan & Gyeongnam (1 Year), Busan
Korea South, 부산, 부산,
게시됨 July 5, 2025
설명
광고
이력서 보내기
고용주 정보

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com.
This page isn't intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk's office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here http://www.novonordisk.com/communityguidelines